University of Texas at Austin
Austin, Texas, 78702, United States
Location status: Recruiting
NCT Number: NCT06511752
The current study aims to examine the benefits of an education/support group program for individuals with progressive aphasia (caused by various etiologies, diagnoses) and their carepartners. The current study utilizes pre-, post-treatment, and follow-up assessments to measure effects of a psychoeducational support group and an implementation/communication skills training phase on measures of psychosocial function, communicative effectiveness and speech/language function. Analysis of study-specific surveys and semi-structured interviews will provide qualitative data regarding outcomes. Before beginning the education and support group, focus groups will be run in order to set priorities for the themes to be included in the education program. Participants will join via tele-based means if preferred and these participants may reside in the United States, or internationally including Mexico and Spain.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Early Phase 1
Austin, Texas, 78702, United States
Location status: Recruiting
Two educational/support group routes will be offered:
The caregiver educational support group path will be delivered in two phases, whereas the PA educational support group path will only consist of the first phase. The first phase of the caregiver educational support group will focus on the educational support group and the second phase will consist of implementation and practice of strategies with feedback provided by the clinician.
The educational/support groups (Routes 1 and 2) will include opportunities for discussion of issues related to language-led dementia or progressive aphasia (e.g., coping with changes in cognition and language, use of strategies for effective communication) and education regarding the disorder provided by relevant experts (e.g., speech-language pathologists, licensed professional counselors), separately for carepartners and individuals with progressive aphasia.
The implementation phase (Route 2, only) will allow for practice of strategies and skills learned in the first phase.
The total amount of time participants will be involved in the study will be 9 months, inclusive of follow-up.
Phase 1. Timeline for the support group portion of the study: Participants will complete pre-treatment measures during a period of 1-2 weeks prior to their first meeting. After four months of twice monthly meetings, post-treatment measures will be completed within 1-2 weeks of treatment completion. Follow-up evaluation will take place at 3-months post-treatment.
Phase 2. Timeline for the implementation/dyad training portion of the study: Post-treatment assessment from Phase 1 will serve as pre-treatment assessment for Phase 2. Treatment sessions will be held once weekly for 4 weeks, and post-treatment assessment will be completed within 1-2 weeks of phase 2 treatment completion. Follow-up evaluation will take place at 3-months post-treatment.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All participants must:
Additional inclusion criteria for PA/ language-led dementia support group participants:
Additional inclusion criteria for care partner support group plus implementation phase participants:
Exclusion criteria
Psychosocial educational, support group and implementation of strategies
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
In-house Acceptability and Perception of Change Survey
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Acceptability scale for healthcare interventions (the Theoretical Framework of Acceptability based questionnaire; Sekhon et al., 2022)
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Adherence/receipt of intervention, 0-100, greater better
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Engagement, 0-100, greater better
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Number of dropouts, reasons for dropout (related to intervention or not), and overall, retention rate at final assessment and follow-up; 80% is successful at the final post-treatment assessment and 80% is successful at the 2-month follow-up, 0-100, greater better
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Aphasia impact, Higher score indicates poorer quality of life (worse) Range of scores for each question: 0-4 Total 0-84
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Cognitive screener, 0-30, greater better
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Aphasia severity, 0-10, greater better
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Quality of life, greater score is better, 0-195
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Aphasia severity, higher score = worse, 0-3
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Neuropsychiatric status, higher score = worse, 0-36
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Dementia Rating, higher score = worse, 0-3
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Quality of life, higher scores is better,14-70
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Quality of life, higher score is better, 28-112
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Depression, higher score is worse, 0-15
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Dementia Knowledge, higher score is better, 0-60
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Depression, higher score is worse, 0- 60
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
General health, higher score is better, 0-100
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Anxiety, higher score is worse, 0-21
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Religion Index
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Familism Scale, higher score= greater religiosity, 1-15 considering all subscales
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Acculturation, higher score is better, 20-124
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Quality of Life, higher score is better, 0 -105
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Coping strategies, higher score is better, 0-6
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Coping strategies, higher score = worse, -28-28
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Burden, higher score = worse, 0-88
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Stress level, higher = worse, 0-40
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Resilience
Time frame: Baseline, Immediately following treatment, Follow-up at 3-months post-treatment
Dementia management, higher score= higher frequency of action, subscales 8-55
Contact information is provided by the study sponsor or research team.
University of Texas at Austin
Other
Educational Support Group Program for Carepartners of Bilingual and Spanish-speaking Persons With Progressive Forms of Aphasia and for Persons With Progressive Forms of Aphasia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05741853
Alzheimer Disease, Aphasia
Austin, Texas, United States
View Trial DetailsNCT05697380
Alzheimer Disease, Aphasia
Chicago, Illinois, United States
View Trial DetailsNCT06529744
Alzheimer Disease, Aphasia
North York, Ontario, Canada
View Trial DetailsNCT04726527
Alzheimer Disease, Aphasia
Chicago, Illinois, United States
View Trial Details